{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:22:33Z","timestamp":1773922953384,"version":"3.50.1"},"reference-count":25,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:00:00Z","timestamp":1425945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Immunotherapy in cancer patients is a very promising treatment and the development of new protocols and the study of the mechanisms of regression is imperative. The objective of this study was to evaluate the production of cytokines in helper T (CD4+) lymphocytes during immunotherapy with pegylated IFN-\u03b1 in patients with cervical intraepithelial neoplasia (CIN). We conducted a prospective study with 17 patients with CIN II-III using immunotherapy with pegylated IFN-\u03b1 subcutaneouly weekly, and using flow cytometry we evaluated the peripheric CD4+ T lymphocytes. The results show that in the regression group the patients presented a significant increase in the amount of IFN-\u03b3 during the entire immunotherapy, compared with the group without a response. The amount of CD4+ T lymphocytes positive for IL-2, IL-4, IL-10 and TGF-\u03b2 is significantly lower in patients with good clinical response. The results also demonstrate that patients with regression have a higher amount of intracellular TNF-\u03b1 in CD4+ T lymphocytes before the start of treatment. Analyzing these data sets, it can be concluded that immunotherapy is a viable clinical treatment for patients with high-grade CIN and that the regression is dependent on the change in the immune response to a Th1 pattern.<\/jats:p>","DOI":"10.3390\/ijms16035497","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T10:59:09Z","timestamp":1425985149000},"page":"5497-5509","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Helper T Lymphocyte Response in the Peripheral Blood of Patients with Intraepithelial Neoplasia Submitted to Immunotherapy with Pegylated Interferon-\u03b1"],"prefix":"10.3390","volume":"16","author":[{"given":"M\u00e1rcia","family":"Michelin","sequence":"first","affiliation":[{"name":"Oncology Research Institute (IPON), Federal University of the Tri\u00e2nguloMineiro (UFTM), Uberaba, Minas Gerais 38022-200, Brazil"},{"name":"Discipline of Immunology, UFTM, Uberaba, Minas Gerais 38022-200, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia","family":"Montes","sequence":"additional","affiliation":[{"name":"Oncology Research Institute (IPON), Federal University of the Tri\u00e2nguloMineiro (UFTM), Uberaba, Minas Gerais 38022-200, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosekeila","family":"Nomelini","sequence":"additional","affiliation":[{"name":"Discipline of Gynecology and Obstetrics, UFTM, Uberaba, Minas Gerais 38022-200, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Trov\u00f3","sequence":"additional","affiliation":[{"name":"Discipline of Gynecology and Obstetrics, UFTM, Uberaba, Minas Gerais 38022-200, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddie","family":"Murta","sequence":"additional","affiliation":[{"name":"Oncology Research Institute (IPON), Federal University of the Tri\u00e2nguloMineiro (UFTM), Uberaba, Minas Gerais 38022-200, Brazil"},{"name":"Discipline of Gynecology and Obstetrics, UFTM, Uberaba, Minas Gerais 38022-200, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2015,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.biocel.2007.07.004","article-title":"Human papillomavirus: E6 and E7 oncogenes","volume":"39","author":"Boulet","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc700","article-title":"Immune evasion in human papillomavirus-associated cervical cancer","volume":"2","author":"Tindle","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","first-page":"239","article-title":"Depressed Type 1 cytokine synthesis by superantigen-activated CD4+ T Cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions","volume":"11","author":"Lee","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.bi.64.070195.003201","article-title":"Transcriptional responses to polypeptide ligands: The Jak\u2013Stat pathway","volume":"64","author":"Schindler","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"ref_5","first-page":"923","article-title":"Interferon-dependent transcriptional activation signal transduction without second messenger involvement","volume":"2","author":"Levy","year":"1990","journal-title":"New Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/smvy.1995.0023","article-title":"Interferon induction of gene expression through the Jak\u2013Stat pathway","volume":"6","author":"Levy","year":"1995","journal-title":"Semin. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1126\/science.156.3783.1760","article-title":"Interferon binding: The first step in establishment of antiviral activity","volume":"156","author":"Friedman","year":"1967","journal-title":"Science"},{"key":"ref_8","first-page":"522","article-title":"Expression of cytokines in cervical stroma in patients with high-grade cervical intraepithelial neoplasia after treatment with intralesional interferon \u03b1-2b","volume":"31","author":"Ramos","year":"2010","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_9","first-page":"1821","article-title":"Preferential induction of apoptosis by interferon (IFN)-\u03b2 compared with IFN-\u03b12: Correlation with TRAIL\/Apo2L induction in melanoma cell lines","volume":"7","author":"Leaman","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"24965","DOI":"10.1074\/jbc.M101161200","article-title":"Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-\u03b2 in ovarian carcinoma cells","volume":"276","author":"Morrison","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood.V98.7.2183","article-title":"Apo2L\/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma","volume":"98","author":"Chen","year":"2001","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1155\/2007\/136906","article-title":"HPV infections in adolescents","volume":"23","author":"Moscicki","year":"2007","journal-title":"Dis. Markers"},{"key":"ref_13","first-page":"111","article-title":"Utilization of interferon in gynecologic and breast cancer","volume":"1","author":"Nomelini","year":"2007","journal-title":"Clin. Med. Oncol."},{"key":"ref_14","first-page":"372","article-title":"Cervical intraepithelial neoplasia treated by perilesional injection of interferon","volume":"93","author":"Choo","year":"1986","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/014107689008300804","article-title":"Effect of perilesional injection of \u03b1-interferon on cervical intraepithelial neoplasia and associated human papillomavirus infection","volume":"83","author":"Dunhan","year":"1990","journal-title":"J. R. Soc. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00007435-199205000-00002","article-title":"Intralesional recombinant \u03b1 2B interferon in the treatment of human papillomavirus-associated cervical intraepithelial neoplasia","volume":"19","author":"Stellato","year":"1992","journal-title":"Sex. Transm. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/030089160409000216","article-title":"Successful pregnancy after vaginal cancer treated with interferon","volume":"90","author":"Murta","year":"2004","journal-title":"Tumori"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/CDLI.6.5.751-755.1999","article-title":"Th1 cytokine patterns in cervical human papillomavirus infection","volume":"6","author":"Scott","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2007\/24147","article-title":"Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, comparared with HR-HPV(\u2212) controls","volume":"2007","author":"Bais","year":"2007","journal-title":"Mediat. Inflamm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.929","article-title":"Quantitative analysis of IL-10 and IFN-\u03b3 mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer","volume":"195","author":"Seth","year":"2001","journal-title":"J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/89.3.245","article-title":"Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papillomavirus infection","volume":"89","author":"Clerici","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_22","first-page":"2972","article-title":"Predominant Th2\/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical","volume":"167","year":"2001","journal-title":"Cancer J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/j.1471-0528.1997.tb10981.x","article-title":"The potential of serum levels of soluble tumor necrosis factor receptor I as a biochemical marker in cervical cancer","volume":"104","author":"Sheu","year":"1997","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00262-005-0051-4","article-title":"Dendritic cells engineered to express CD40L continuously produce IL 12 and resist negative signals from Tr1\/Th3 dominated tumors","volume":"55","author":"Loskog","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/onci.27528","article-title":"Interferon-\u03b1 interferes with immunological tolerance","volume":"2","author":"Becker","year":"2013","journal-title":"Oncoimmunology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/3\/5497\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:43:20Z","timestamp":1760215400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/3\/5497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,10]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3]]}},"alternative-id":["ijms16035497"],"URL":"https:\/\/doi.org\/10.3390\/ijms16035497","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,10]]}}}